Top compounds associated with response to GIMD1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.0056 0.9
mRNA SN-38 CTRPv2 pan-cancer AAC -0.0056 0.9
mRNA purmorphamine CTRPv2 pan-cancer AAC -0.0057 0.9
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.0052 0.9
mRNA isonicotinohydroxamic acid CTRPv2 pan-cancer AAC -0.0069 0.9
mRNA cimetidine CTRPv2 pan-cancer AAC 0.0098 0.9
mRNA erastin CTRPv2 pan-cancer AAC -0.0051 0.9
mRNA B02 CTRPv2 pan-cancer AAC -0.0053 0.9
mRNA VU0155056 CTRPv2 pan-cancer AAC -0.0055 0.9
mRNA Parthenolide CTRPv2 pan-cancer AAC -0.0054 0.9
Download CSV